Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021유럽에서 델타 순환이 우세한 동안 1차 진료 및 지역사회 수준에서 COVID-19에 대한 완전한 1차 백신 접종의 효과: 다중 센터 분석, I-MOVE-COVID-19 및 ECDC 네트워크, 2021년 7월~8월Multicenter Study Published on 2022-05-012022-09-11 Journal: Eurosurveillance [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI acute respiratory symptom acute respiratory symptoms Analysis circulation Community Complete Course COVID-19 COVID-19 vaccine Delta delta variant ECDC Effectiveness Europe European country janssen multicentre multicentre study Older predominant primary care Sample size SARS-CoV-2 symptomatic symptomatic infection test-negative design tested the SARS-CoV-2 the vaccine vaccination vaccination against COVID-19 Vaccine vaccine effectiveness while with COVID-19 [DOI] 10.2807/1560-7917.ES.2022.27.21.2101104 PMC 바로가기 [Article Type] Multicenter Study
Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022) : Updated statement of the Austrian Society of Pneumology (ASP)만성 폐 질환 환자에 초점을 맞춘 SARS-CoV-2 감염 환자 관리(2022년 1월 10일 기준) : 오스트리아 폐렴 학회(ASP)의 업데이트된 성명Article Published on 2022-05-012022-09-11 Journal: Wiener Klinische Wochenschrift [Category] Coronavirus, COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition addressed Adults affected ASP association breakdown bronchoscopy Care cause children chronic chronic lung disease chronic lung diseases concerning coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 disease delta variant died disease effective elevated expected Health health system Immune modulators increased risk Infection lockdown Long Long COVID lung Lung disease Lung function measure Mechanical mechanical ventilation Most patients Omicron variant Patient patients patients with SARS-CoV-2 Pediatric lung disease. Pneumology predominant Prevent professional provided reaction rising risk risk of death SARS-CoV-2 SARS-CoV‑2 SARS-CoV‑2 infection severe acute respiratory syndrome Coronavirus severe COVID-19 disease social distancing Society Spread therapy vaccination vaccination rate Vaccinations variant [DOI] 10.1007/s00508-022-02018-x PMC 바로가기 [Article Type] Article
Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: a test-negative design study브라질 리우데자네이루의 사회적 취약 지역 사회에서 COVID-19에 대한 ChAdOx1 nCoV-19의 백신 효과: 테스트 음성 설계 연구Article Published on 2022-05-012022-09-11 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted age Asymptomatic individuals Brazil ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 against circulating Community conducted COVID-19 COVID-19 infection Delta effective Effectiveness first and second dose first dose Gamma Infection logistic regression models median time negative test positive predominant Primary outcome qPCR test reducing Rio de Janeiro RT-qPCR RT-qPCR test second dose secondary outcome selected Symptom symptomatic symptomatic COVID-19 Test-negative the median vaccination Vaccine variant Vulnerable community. was obtained [DOI] 10.1016/j.cmi.2022.01.032 PMC 바로가기 [Article Type] Article
COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry간경변증의 COVID-19 사망률은 간경변증 관련 동반 질환 및 간외 장기 부전에 의해 결정됩니다. 다국적 LEOSS 등록의 결과Article Published on 2022-05-012022-09-11 Journal: United European gastroenterology journal [Category] COVID19(2023년), SARS, 변종, [키워드] 28-day mortality ACLD age Alpha Alpha variant Analysis Bacterial Bacterial infection bacterial peritonitis cardiovascular disease Case fatality rate chronic liver disease cirrhosis Comorbidities Comorbidity contribute COVID-19 COVID-19 case COVID-19 mortality death demographics determined by diabetes disease Disease progression Diseases eligible European Factor fatality high mortality rate highest Hospitalized identify immunologically Infection liver Liver disease liver failure Mortality naïve obesity Odds ratio organ Organ failure Patient patients older patients with SARS-CoV-2 predominant propensity score matching PSM renal renal disease reported Result Risk factors SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-infected patient SARS-CoV-2-infected patients SBP severe COVID-19 Sex significantly smoking status survey Symptoms variant wild-type wild-type SARS-CoV-2 [DOI] 10.1002/ueg2.12232 PMC 바로가기 [Article Type] Article
The clinical course, biochemical markers, and clinical outcomes of COVID-19 positive patients from the third wave in Pakistan: A retrospective cohort studyResearch article Published on 2022-05-012022-10-05 Journal: Annals of Medicine and Surgery [Category] 바이오마커, [키워드] affected Analysis ARDS Asymptomatic being biochemical marker biochemical markers Case fatality rate Clinical course clinical marker Clinical outcome COVID-19 COVID-19 positive patient cumulative death diabete diagnosed with COVID-19 disease course disease severity Dyspnea expected expired Fever Gastrointestinal hypertension ICU include individual Infection intensive care patient interstitial Kaplan-Meier survival analysis median age Mortality non-survivor occurred outcomes pandemic patchy Patient PCR polymerase chain Predictive predominant Probability radiological finding recovered patient reduced Result retrospective cohort study SARS-CoV-2 second wave severity severity and prognosis surpassed survival survivor Symptom the patient transmissions variant ventilator X-ray [DOI] 10.1016/j.amsu.2022.103599 [Article Type] Research article
Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosusObservational Study Published on 2022-05-012022-10-05 Journal: Clinical Rheumatology [Category] COVID19(2023년), SARS, 임상, [키워드] (MeSH NLM): Coronavirus Autoimmune diseases BNT162b2 BNT162b2 vaccine COVID-19 Department died disease dose doses Effect Hospitalized Hydroxychloroquine identify immunization immunized intensity Local lower risk Mild occurred Pain Patient Pfizer Point predominant presenting renal Renal involvement risk SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine severity side Side effect SLE SLE patient Symptom systemic systemic lupus erythematosus the vaccine use of hydroxychloroquine vaccination Vaccines [DOI] 10.1007/s10067-021-05980-5 PMC 바로가기 [Article Type] Observational Study
Coronavirus disease 2019 transmission and symptoms in young children during the severe acute respiratory syndrome coronavirus 2 Delta variant and Omicron variant outbreaks중증 급성 호흡기 증후군 코로나바이러스 2 델타 변이체 및 오미크론 변이체 발병 시 코로나바이러스 질병 2019 전염 및 어린이의 증상Article Published on 2022-05-012022-09-11 Journal: The Journal of international medical research [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome B.1.1.529 B.1.617.2 Chain Reaction children clinical symptom Clinical symptoms close contact coronavirus coronavirus disease Coronavirus disease 2019 cough COVID-19 COVID-19 transmission Delta delta variant disease disease transmission evaluated fatigability Fever independent independent of Japan location Mass screening Nasopharyngeal swab not different omicron Omicron variants outbreak pandemic polymerase chain reaction predominant prevalence rate prevalence rates risk of COVID-19 screening test secondary transmission significantly higher strain Symptom Transmissibility Transmission variant variant strain variants young child young child. [DOI] 10.1177/03000605221102079 PMC 바로가기 [Article Type] Article
Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies – United States, September 2021-February 2022감염 유도 SARS-CoV-2 항체의 혈청 유병률 - 미국, 2021년 9월-2022년 2월Article Published on 2022-04-292022-09-11 Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] age Asymptomatic B.1.1.529 capture cause CDC community survey COVID-19 COVID-19 case diagnosed Disease surveillance highest IMPROVE incidence of COVID-19 Laboratory National omicron peaked predominant proportion recorded SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 seroprevalence Seroprevalence survey The United States Traditional traditional methods United States variant of SARS-CoV-2 virus [DOI] 10.15585/mmwr.mm7117e3 PMC 바로가기 [Article Type] Article
The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in MexicoSARS-CoV-2의 알파 변종(B.1.1.7)은 멕시코에서 지배적이지 못했습니다.Article Published on 2022-04-272022-09-11 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Alpha analyses analyzed B.1.1.7 B.1.1.7 lineage can not center circulation community transmission coronavirus coronavirus disease Coronavirus disease 2019 country COVID-19 dispersion distribution Diversity event events excluded exhibited Frequency genomic Genomic surveillance global public health Haplotype highest increase in independent Lineage lineages Mexico occurred pandemic Phylogenetic predominant Prevalence rapid increase reached reported SARS-CoV-2 severe acute respiratory syndrome Coronavirus shown specific mutation specific mutations Surveillance sustained The B.1.1.7 The United States Transmissibility Transmission United Kingdom United States [DOI] 10.1128/spectrum.02240-21 PMC 바로가기 [Article Type] Article
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational ProfileSARS-CoV-2 우려의 오미크론 변종 및 그 특이한 돌연변이 프로필에 대한 업데이트Article Published on 2022-04-272022-09-11 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] ACE2 acquisition acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition Alpha antigenicity assist B.1.1.519 B.1.1.529 Beta binding affinity characterized clinical implications concern coronavirus COVID-19 Critical defined Deletion deletions Delta description diagnostic domains emerging variants functional Gamma Genetic GISAID database knowledge mapped Mutation mutational spectrum mutations omicron Omicron variant pandemic predominant profile Receptor-binding domain residue residues retrieved SARS-CoV-2 SARS-CoV-2 spike protein severe acute respiratory syndrome Coronavirus spike glycoprotein spike mutation Spike protein the receptor-binding domain the SARS-CoV-2 therapeutic three-dimensional structure Transmissibility vaccine-induced antibodies vaccine-induced antibody variant variant of concern variants Viral proteins VoC Whole-genome sequence [DOI] 10.1128/spectrum.02732-21 PMC 바로가기 [Article Type] Article